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Introduction: Sufficient uterine blood supply is essential for the fetus to develop normally in the uterus. Several
mechanisms are involved in the process of vessel development in deciduas and villus. We focus on whether
first-trimester decidua side population (SP) cells contain cells capable of differentiating into endothelial cells.
Methods: Eight decidua samples were collected from healthy women, 22- to 30-years old, undergoing elective
terminations of early pregnancy (six to eight gestational weeks). The cell suspensions from human deciduas
were stained by Hoechst 33342 and sorted by flow cytometry, further cultured under differentiation conditions
and analyzed for specific markers. These cells were implanted into ischemic limbs of nude mice to test the
capacity of angiogenesis in vivo by DiI tracers and immunohistochemistry.
Results: Decidua CD31-CD146- SP cells of first-trimester human pregnancy can differentiate into endothelial
cells, express the corresponding specific markers of endothelial cells, such as CD31 and CD146, and form tube-
like structures on Matrigel and part of newly formed vessels in the ischemic limbs of nude mice. Vascular
endothelial growth factor was more effective in promoting proliferation of CD31-CD146-SP cells compared with
other growth factors, and estrogen and progesterone at a final concentration of 10 μmol/L and 30 μmol/L,
respectively, promoted the migration of CD31-CD146-SP cells in a dose-dependent manner.
Conclusions: CD31-CD146- SP cells may be involved in the formation of new vessels in the maternal aspect of
the placenta in the first trimester.
Keywords: Human decidua, Side population cells, Differentiation potential, NeovascularizationIntroduction
Sufficient nourishment is essential for a fetus to develop
normally in the uterus. Abnormal uterine blood supply is
associated with higher miscarriage, preterm delivery, pre-
eclampsia and intrauterine growth restriction [1–3]. To
meet the rising needs of the fetus, both vasodilation and de-
velopment of new vessels occur during pregnancy. Evidence
from several studies confirms that the vascular density of
decidua tissues increases quickly in the first trimester and
continues to increase slowly throughout gestation [4–6].
Many research studies have described the development of
new blood vessels in the early placenta, especially the fetal
aspects, in detail including the formation mechanism, the* Correspondence: weihuang64@163.com
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reproduction in any medium, provided the ormolecular profile changes of the endothelial complexes and
their molecular regulation, and the respective growth fac-
tors [7–9]. The maternal aspect of the placenta was usually
reputed to be the remodeling of the maternal uterine ves-
sels [10]. Actually, the endometrium is rich in stem cell-like
cells [11–13]. Since side population (SP) cells were found
by Goodell and used to isolate these stem cell-like cells
[14], several researchers have focused on the SP cells in the
human endometrium [15,16], and they found that these
cells could differentiate into adipose cells, bone cells and
endothelial cells. However, research on decidua cells in
early pregnancy has been rare. Our previous work identified
stem/progenitor cells in the deciduas of human first-
trimester fetuses by using fluorescent Hoechst dye 33342 to
isolate SP cells. These SP cells have been proven to form
clones and have differentiated into decidua mesenchymal
cells [17,18]. Recently, we found that the subfraction of
CD31-CD146- SP cells revealed distinct properties, andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vascular endothelial growth factor (VEGF), estrogen and
progesterone in vitro. In addition, the CD31-CD146-SP cell
subfraction caused functional revascularization in hind limb
ischemia in vivo. Therefore, SP cells in decidua may play a
role in the process of new blood vessel development in the
maternal placenta. In this study, we investigated the differ-
ent factors required for the induction of CD31-CD146- SP
cells to endothelial cells in vitro and confirmed the findings
in further animal experiments.Methods
Study population
This study was performed in accordance with the Declar-
ation of Helsinki and approved by the Medical Research
Review Board of West China Second University Hospital
of Sichuan University (2009023). Eight healthy women at
six to eight weeks gestation who sought a surgical termin-
ation of pregnancy for personal reasons were enrolled in
the study. Gestational age was calculated from the last
menstrual period and confirmed by ultrasound measure-
ments of the gestational sac and fetal bud (the fetal bud
was seen in three cases). Clinical details were recorded for
each woman; they were 22– to 30-years old and had regu-
lar menstrual periods and a normal pregnancy without
any pregnancy-related disorders or any medicine usage
within the prior three months. Each woman gave signed
informed consent.
The nude mice used in this study were five- to six-
week-old, healthy, weighed 16 to 18 g, and were housed
and fed in a specific-pathogen free (SPF) environment.
The study was approved by the ethical committee of
West China Second University Hospital of Sichuan
University.Flow cytometry
The primary decidua cells from human first-trimester
fetuses (n = 8) were separated, cultured for 24 to 48
hours and then digested and labeled with Hoechst
33342 (Invitrogen, Paisley, UK) as previously described
[17,18]. Then the cells were incubated with mouse anti-
human CD31 (fluorescein isothiocyanate (FITC), BD
Biosciences San Jose, CA, USA) and mouse anti-human
CD146 (phycoerythrin (PE), BD Biosciences) for 20
minutes at 4°C. Analysis/sorting of cells was performed
using a flow cytometer BD aria2 special order containing
355 UV (BD Biosciences).Cell cultures
We adopted suitable culture medium conditions to main-
tain the sorted CD31-CD146- SP cells, using EBM2 (LonzaWalkersville, MD, USA), including growth factors such as
insulin-like growth factor (IGF) -1 and epidermal growth
factor (EGF) [19]. The medium used for inducing SP cells
into endothelial cells was basic fibroblast growth factor
(bFGF) and vascular endothelial growth factor (VEGF) –A.
The cell fraction was plated onto collagen type I-coated
dishes (BD Biosciences) in EBM2 supplemented with suit-
able growth factors. The medium was changed every four
to five days. Once cells reached 50% to 60% confluence,
they were detached by incubation with 0.25% trypsin
containing 0.02% ethylenediaminetetraacetic acid (EDTA)
at 37°C for 5 minutes and subcultured at a 1:3 dilution
under the same conditions for more than 20 passages.Proliferation, chemotaxis and migration assay
To measure proliferation of CD31-CD146- SP cells com-
pared with non-SP cells, at the third passage (at 103 cells
per 96-well plate) these cells were cultured in EBM2
supplemented with 0.2% fetal bovine serum (FBS, GIBCO
BRL, Gaithersburg, MD, USA) and bFGF (50 ng/ml; R&D
Systems, Minneapolis, MN, USA), VEGF (50 ng/ml; R&D
Systems), EGF (50 ng/ml, R&D Systems), and IGF1
(50 ng/ml; R&D Systems). Then, 10 μl Cell Counting Kit-8
(CCK-8 Beyotime) per well was added to the 96-well plate.
After two hours in the cell incubator, cell numbers were
measured using a spectrophotometer at 450 nm absorb-
ance at 0, 12, 24, 36, 48 and 72 hours of culture. Wells
without cells served as negative controls.
To examine the chemotaxis and migration activity of
CD31-CD146- SP cells, 5 × 104 cells were seeded on a
Boyden chamber (BD Biosciences) with 8 μm polycarbon-
ate membranes inserted into a 24-well assembly containing
EBM2 supplemented with VEGF at a final concentration of
0, 5, 10 or 100 ng/ml, estrogen (Sigma-Aldrich St. Louis,
MO, USA) at a final concentration of 0.01, 0.1, 1 or 10
μmol/L and progesterone (Sigma-Aldrich) at a final con-
centration of 0.03, 0.3, 3 or 30 μmol/L. After 24 hours, the
chambers were stained with 0.1% crystal violet and
analyzed by photography of the stained cells that had
migrated or chemotaxis cells in the lower chamber. The
migration or chemotaxis cells were counted in five random
fields of vision.Endothelial differentiation in vitro
The freshly sorted CD31-CD146- SP cells were cultured
with EBM2 supplemented with 10% FBS, bFGF (10 ng/ml),
and VEGF (50 ng/ml). After 21 days culture through four
to five passages, the cells were incubated with mouse anti-
human CD31 and mouse anti-human CD146 for 20 mi-
nutes at 4°C, then were analyzed on the flow cytometer. To
detect the endothelial function, these cells at a seeding
density of 2.0 × 105 were seeded on the Matrigel matrix
(11.0 mg/ml) (BD Biosciences) in EGM2.
Figure 1 Flow cytometric analyses for sorting side population cells and its CD31 and CD146 subfraction. The SP fraction comprised
1.59% of the total cells (A), and Hochest 33342 and verapamil staining both ruled out false positive SP cells in the total cells (B). This experiment
was repeated eight times, and the SP fractions were 1.368 ± 0.393%. The negative control for the CD31CD146 cells (C). The CD31-CD146- cells
comprised 95.6% of the total SP cells and the other three subgroups shared less than 5% of the total SP cells (D). The flow cytometric analyses of
the cells after being cultured in the differentiation media showed that the CD31+CD146+ cells comprised 93.1% of the total SP cells (E). Data are
expressed as means ± SD. The experiments were repeated three times and one representative experiment is presented. SP, side population.
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The potential of neovascularization of human decidua
CD31-CD146- SP cells was examined in a murine model
of hind limb ischemia in five- to six-week-old nude mice
[20]. After subcutaneous anesthesia with pentobarbitalsodium, the proximal portion of the femoral artery, includ-
ing the superficial and the deep branches and the distal
portion of the saphenous artery, were ligated. After 24
hours, 100 μl of PBS with or without 1 × 106 freshly de-
tached CD31-CD146- SP cells at the third to fifth passage
Figure 2 The proliferation of CD31-CD146-SP cells and non-SP cells. CD31-CD146-SP cells and non-SP cells were treated with 0.2% FBS, VEGF,
bFGF, EGF and IGF. All factors can promote CD31-CD146-SP cell proliferation and have a significant difference between two types of cells (A-E)
(P <0.01). Data are expressed as means ± SD. Statistical analysis was performed by the non-paired Student’s t test. The experiments were
repeated three times and from three patients’ decidua, but one representative experiment is presented. bFGF, basic fibroblast growth factor; EGF,
epidermal growth factor; FBS, fetal bovine serum; IGF, insulin-like growth factor G; SP, side population; VEGF, vascular endothelial growth factor.
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(DMSO) incubated for 20 minutes) labeling was injected
intramuscularly into the distal limb. Then the skin color
and temperature, necrosis or growth after ligation of the
hind limb was investigated. The mice were fed as before
the procedure.
After 21 days, the mice were executed and the muscle
tissues of the ischemic hind limb were isolated, fixed and
embedded. Serial paraffin sections were stained with
mouse anti-human CD54 antibody (Santa) using immuno-
histochemistry (IHC). The concentration of CD54 was
1:100. The IHC kit was purchased from Zhongshan
Biotech Co., Ltd (Beijing, China). Human colorectalcarcinoma tissue was used as the positive control and nor-
mal mouse immunoglobulin G (IgG) was used instead of
monoclonal antibody in the negative control group. The
red fluorescent signal of the transplanted cells observed
by fluorescence microscopy (Olympus) confirmed the
localization of the transplanted cells and their relation to
newly formed blood vessels.Statistical analyses
Data are reported as means ± SD. P values were calculated
using the unpaired Student’s t test. The number of repli-
cates in each experiment is indicated in the figure legends.
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Isolation of CD31-CD146-SP cells from human first-
trimester deciduas
Flow cytometric analyses showed 1.368 ± 0.393% SP gran-
ules isolated from human first-trimester decidual tissues
(n = 8) (Figures 1A, 1B). By using antibodies against CD31
and CD146, further distinct subpopulations were isolated.
CD31 is known to be highly expressed in endothelial pro-
genitor cells and endothelial cells, and CD146 in smooth
muscle cells and endothelial cells. The CD31-CD146- cells
represented 94.51 ± 2.41% of the total SP cells. The other
three subgroups were seen in less than 5% of the total SP
cells (Figure 1D).
Proliferation activity, migration of CD31-CD146 -SP cells
In the presence of different growth factors and sex hor-
mones CD31-CD146-SP cells and non-SP cell populations
proliferated differently. There was a progressive increase
with time in the response to the various factors. On day
three, VEGF, bFGF, EGF, and IGF treatment enhancedFigure 3 The migration activity of CD31-CD146- SP cells. The migration
Data are expressed as means ± SD (*, P <0.01) (A). The migration of CD31-CD14
(C). The minimum concentration of estrogen and progesterone can induce sign
paired Student’s t test. The experiments were repeated three times and from th
side population; VEGF-A, vascular endothelial growth factor - A.proliferation of CD31-CD146-SP cells, almost two times
more than in non-SP cells and the control treated with
0.2% FBS only (Figures 2A-2E). VEGF was more effective
in enhancing proliferation of CD31-CD146-SP cells com-
pared with the other growth factors at different induction
times and inducted CD31-CD146-SP cell proliferation in a
dose-dependent manner (Figure 3A). Estrogen and proges-
terone at final concentrations of 10 μmol/L and 30 μmol/
L, respectively, also promoted the migration of CD31-
CD146-SP cells in a dose-dependent manner (Figures 3B,
3C).
Differentiation of CD31-CD146- SP cells into endothelial cells
CD31-CD146-SP cells were cultured in the EBM2 supp-
lemented with 10% FBS, 50 ng/ml VEGF and 10 ng/ml
bFGF; after 21 days in vitro culture, 92.37 ± 2.09% of
CD31-CD146-SP cells expressed both CD31 and CD146 in
flow cytometric analyses (Figure 1E).
The endothelial differentiation potential was assessed by
tube formation assay. Extensive networks of cords andactivity with VEGF-A at a final concentration of 0, 5, 10, and 100 ng/ml.
6-SP induced by estrogen (10 μmol/L) (B) and progesterone (30 μmol/L)
ificant migration (P < 0.01). Statistical analysis was performed by the non-
ree patients’ decidua, but one representative experiment is presented. SP,
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CD146-SP cells cultured on Matrigel as early as 48 hours.
The network of cords typically associated with endothelial
cells, suggesting an angioblast phenotype (Figures 4A, 4C).
Inversely, non-SP cells formed only short strands on
Matrigel (Figures 4B, 4D).
Neovascularization in the ischemic hind limb of
nude mouse
Immediately after the ligated limbs were cut, the toes of
the ligated limbs were pale (Figure 5A). After 24 hours, the
limbs treated by ligation exhibited necrosis of limb extrem-
ity when compared to the non-ligated limb (Figure 5B).
Twenty-one days after transplantation, compared to the
limb treated with PBS only (Figure 5D), the left limb of the
mice transplanted with CD31-CD146-SP cells was longer
(Figure 5C). We also found cells staining red (tracing the
CD31-CD146-SP cells) in the ischemic hind limb using
fluorescence microscopy. These cells were CD 54 positive
and formed part of the blood vessel in serial paraffin
sections (Figure 6A, 6C) but they did not appear in the
PBS-treated limbs (Figures 6B, 6D). Among newly formed
capillaries, the number of two positive cells increased dem-
onstrating numerous migrating cells to form new vessels.Figure 4 The tube formation assay for induced CD31-CD146-SP cells 2
extensive network of cords and tube-like structures can be seen on Matrig
strands formed in non-SP cells after 48 hours (B, D). The experiment was re
SP, side population.The isolatation of the SP cells from hematopoietic stem
cells for the efficiency of efflux of the dye Hoechst 33342
accounts for the uniquely low fluorescence of the SP
population [13]. This method has been used for the identi-
fication of putative somatic stem cells in several human
tissues, including human endometrium [15,19,21–23].
There is increasing evidence of multilineage differentiation
of tissue SP cells including human endometrial SP cells
[15,16,24,25]. Cervello et al. [26] concluded that the hu-
man endometrial SP cells exhibit genotypic, phenotypic
and functional features of somatic stem cells, and demon-
strated the functional capability of endometrial SP to
develop human endometrium after subcutaneous injection
in NOD-SCID mice. Furthermore, they found that
bone marrow derived stem cells may be a limited source
of transdifferentiated endometrial cells, but SP cells in the
endometrium maybe play a key role for the mature
endometrium [27].
Our study focused on the subfractionation of CD31-
CD146-SP cells from human decidua to assess their differ-
entiation into endothelial cells. Our previous work has
proved that SP cells from human decidua can proliferate
and form colonies during long-time culture in vitro and dif-
ferentiate into mesenchymal cells [17,18].1 days after induction at passage 3 to 4 and non SP cells. An
el by induced CD31-CD146-SP cells after 48 hours (A, C), and only short
peated three times, and one representative experiment is presented.
Figure 5 Nude mouse model (n = 8) of ischemic hind limb and transplanted SP cells (implant group n = 4) or PBS (control group n = 4) after
21 days. The blood supply of the hind limbs changed immediately after ligation (right) compared with non-ligation (left) (A). After 24 hours, the limbs
treated by ligation (left) presented necrosis of the extreme limb when compared to the non-ligated limb (right) (B). The limbs of the SP cell implant
group and the control group are compared (C and D). PBS, phosphate-buffered saline; SP, side population.
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lateral plate mesodermal and differentiate into endothelial
progenitor cells (EPC) and angioblasts derive from inter-
mediate mesodermal and finally differentiate into mature
endothelial cells. Usually EPCs and the early angioblasts ex-
press CD34, CD133 and VEGFR2, while our data showedFigure 6 Dil tracing cells observed under fluorescence microscopy an
and significantly formed part of one vessel in an amputated nude mouse limb
anti-human CD54 can be found in corresponding DiI positive cells, which indica
limb had no positive signal or staining (D). PBS, phosphate-buffered saline; SP, sthat the SP cells did not express the haemopoietic stem
cell’s phenotype CD34, CD45, CD133, and CD117, but they
expressed CD44, just like the mesenchymal stem cell
(MSC) [18]. It has been proven that the MSCs can differen-
tiate into endothelial cells in the uterus [22,28]. So, the SP
cells may be the precursors of EPCs. CD31 is expressedd immunohistochemistry. The DiI tracing SP cells emerged near vessels
(A) but there was no signal in the PBS-treated limb (B). The positive mouse
tes that the vessel was composed of differentiated SP cells (C); the control
ide population.
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EPCs and mature endothelial cells [29], and the expression
of CD146 increases in the differentiated endothelial cells
[30]. In the present study, the induced cells were oblong-
shaped and expressed CD31 and CD146 after 21 days. The
functional ability of neovascularization of CD31-CD146-SP
cells was determined and it was demonstrated that they
formed extensive networks of cords and tube-like struc-
tures on Matrigel. Unil now, the decidua vasculogenesis
and angiogenesis did not have proper animal models, so
we tested the neovascularization function of CD31-
CD146- SP cells in the mouse hind limb ischemia model.
The results implied that they can differentiate to func-
tional endothelial cells and these cells can form vessels
in vivo. As the remodeling of spiral arteries is important in
decidualization, our results show that CD31-CD146- SP
cells may play an important role in this process and affect
the pregnancy outcome.
Recently, Masuda et al. [31] have reported that endo-
metrial SP cells have endothelial cell-like properties and
can be induced into mature endothelial cells in vivo and
in vitro. Maybe the endometrial and decidual SP cells are
the same cells just under a different phase for the endo-
metrium. The differences between these two cells may
need more research.
Many studies [32–34] have investigated and found the
promoting effects of estrogen and progestin on the prolif-
eration, migration and functions of human umbilical vein
endothelial cells, EPCs and endometrial endothelial cells.
We found estrogen and progestin both promoted the de-
cidua SP cells to proliferate and migrate. Although this
effect was in a dose-dependent manner, there was a max-
imum dose. The increasing of estrogen and progestin
along with gestation maybe promote the decidua SP cells
to differentiate, proliferate, migrate and finally form func-
tional microvessels in the first trimester.
Conclusions
As a conclusion, the decidua-derived CD31-CD146-sub-
fraction of SP cells is vasculogenic, and may induce
vasculogenesis in vivo in the amputated nude mouse model.
Until now, with an understanding of the mechanisms of
angiogenesis and the roles of angiogenic factors during im-
plantation, new insights and possible approaches will be
provided for embryo implantation and healthy pregnancy.
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